Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yellow Fever Vaccine Long-term Immunity in Argentina
NCT05644145Active, not recruiting
- Sponsor
- Ministerio de Salud
- Start
- Dec 2022
- Primary completion
- Sep 2023
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Open-label, single-arm trial of 17D yellow fever vaccine in yellow fever, sponsored by Ministerio de Salud. Primary endpoint: Proportion of the pediatric population seropositive for yellow fever. Started Dec 2022; status: active, not recruiting.
02
Drugs
17D yellow fever vaccine
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT05644145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05644145.